1. Academic Validation
  2. Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2

Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2

  • Sci Bull (Beijing). 2021 May 15;66(9):925-936. doi: 10.1016/j.scib.2020.12.005.
Chenjian Gu 1 Yang Wu 1 Huimin Guo 1 Yuanfei Zhu 1 Wei Xu 1 Yuyan Wang 1 Yu Zhou 2 Zhiping Sun 3 Xia Cai 3 Yutang Li 1 Jing Liu 1 Zhong Huang 2 Zhenghong Yuan 1 Rong Zhang 1 Qiang Deng 1 Di Qu 1 3 Youhua Xie 1 4
Affiliations

Affiliations

  • 1 Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Institute of Infectious Diseases and Biosecurity, Shanghai Medical College, Fudan University, Shanghai 200032, China.
  • 2 CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
  • 3 BSL-3 Laboratory of Fudan University, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China.
  • 4 Children's Hospital, Shanghai Medical College, Fudan University, Shanghai 201102, China.
Abstract

The SARS-CoV-2 Infection is spreading rapidly worldwide. Efficacious Antiviral therapeutics against SARS-CoV-2 is urgently needed. Here, we discovered that protoporphyrin IX (PpIX) and verteporfin, two Food and Drug Administration (FDA)-approved drugs, completely inhibited the cytopathic effect produced by SARS-CoV-2 Infection at 1.25 μmol/L and 0.31 μmol/L, respectively, and their EC50 values of reduction of viral RNA were at nanomolar concentrations. The selectivity indices of PpIX and verteporfin were 952.74 and 368.93, respectively, suggesting a broad margin of safety. Importantly, PpIX and verteporfin prevented SARS-CoV-2 Infection in mice adenovirally transduced with human angiotensin-converting Enzyme 2 (ACE2). The compounds, sharing a porphyrin ring structure, were shown to bind viral receptor ACE2 and interfere with the interaction between ACE2 and the receptor-binding domain of viral S protein. Our study suggests that PpIX and verteporfin are potent Antiviral agents against SARS-CoV-2 Infection and sheds new LIGHT on developing novel chemoprophylaxis and chemotherapy against SARS-CoV-2.

Keywords

ACE2; Protoporphyrin IX; SARS-CoV-2; Verteporfin.

Figures
Products